Should Antibacterials Be Deregulated?
Year of publication: |
1998
|
---|---|
Authors: | Rovira, Joan ; Figueras, Montserrat ; Segu, Josep L. |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 13.1998, 5, p. 499-508
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Antibacterials | Pharmacoeconomics | Health-policy | Regulatory-process | Bacterial-infections | OTC-drugs | Cost-analysis |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Cefotaxime: A Pharmacoeconomic Review of its Use in the Treatment of Infections
Plosker, Greg L., (1998)
-
Meropenem: A Pharmacoeconomic Review of its Use in Serious Infections
Holliday, Stephen M., (1998)
-
Cost Comparison of Antibacterial Therapies for Serious Infections: A New Zealand 3-Hospital Study
Scott, W. Guy, (1999)
- More ...
-
Financial challenges of health care reform in Nicaragua
Costa, Montse, (2004)
-
Determinants of out-of-pocket pharmaceutical expenditure and access to drugs in Catalonia
Costa-Font, Joan, (2007)
-
La evaluación económica en salud y la toma de decisiones en Iberoamérica
Rovira Forns, Joan, (2005)
- More ...